Navigation Links
LSU receives $2 million from NIH for biomedical sciences training for underrepresented students

LSU Professor Graca Vicente was recently awarded a grant of more than $2 million from the National Institutes of Health, or NIH, to continue Phase III of the Initiative for Maximizing Student Development, or IMSD. She is the Charles H. Barr Distinguished Professor of Chemistry and Professor of Chemotherapy/Materials in the Department of Chemistry at LSU.

"The renewal of Phase III of the IMSD Program is giving us the opportunity to continue to provide research training and career development for LSU students," said Vicente. "It is also an opportunity to build and promote faculty collaborations, develop partnerships with other training programs and increase minority representation in Ph. D. and post-Ph. D. programs across the world."

Vicente serves at the director of IMSD, which provides research training, academic development and career opportunities in the biomedical and behavioral sciences to underrepresented minority graduate and undergraduate students at LSU.

LSU is one of a select group of universities in the United States to establish this program. IMSD has been supported since 2004 by the National Institutes of Health and Phase III, the third round of funding for IMSD, is funded through 2018. Phase I included a $546,000 award for four years (2004-2008) and Phase II was a competitive renewal for the following four years of $970,000 thousand (2009-2013).

Phase III differs from Phases I and II because, in addition to supporting the research of LSU undergraduate students, it also supports graduate students conducting research in the biomedical or behavioral sciences.

IMSD works to consistently produce graduates who rank among the most highly talented, motivated and productive research scientists in the nation. The LSU IMSD Scholars pursue successful research careers and leadership positions, and are among the most sought-after candidates nationwide for entrance into Ph.D. or post-Ph.D. programs.

"The IMSD Program has very special value to me because I am myself a minority Latino/Hispanic woman in the basic sciences," said Vicente. "One of my personal goals has always been to increase minority representation in research, particularly in the basic sciences."

She received her doctoral degree in chemistry from the University of California-Davis in 1990. She completed postdoctoral fellowships at the University of Bourgogne in France (1991), the University of Geneva in Switzerland (1991-1993) and ITQB (Research Institute) in Portugal (1993).

Her research interests include synthesis and investigation of physiochemical and biological properties of new fluorescent pyrrole-based compounds and their development for application in biology and medicine, such as bio-imaging, diagnosis, photodynamic therapy and boron neutron capture therapy of cancer.


Contact: Ashley Berthelot-Arceneaux
Louisiana State University

Related biology news :

1. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
2. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
3. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
4. Gladstone scientist Warner C. Greene receives Washington University School of Medicine Alumni Award
5. Carnegies Wolf B. Frommer receives Bogorad Award for Excellence in Plant Biology
6. UC Riverside plant cell biologist receives top scientific honor
7. UC Riverside receives grant for global health and development research
8. Washington University receives $8 million to lead international childhood malnutrition effort
9. SRI Sarnoffs Iris on the Move® N-Glance™ Identification System Receives Lenel Factory Certification
10. SF State biology department receives $1.5 million to support science teaching
11. Dr. Karen Lloyd receives WHOIs Holger W. Jannasch Visiting Scholar Award
Post Your Comments:
(Date:11/18/2015)... new scientific discoveries deepen our understanding of how cancer ... challenges in better using that knowledge to guide treatment ... children continue to survive pediatric cancer, that counseling may ... John M. Maris, M.D ., a pediatric oncologist ... --> John M. Maris, M.D ., ...
(Date:11/17/2015)... , November 17, 2015 Paris ...   --> Paris from 17 th ... DERMALOG, the biometrics innovation leader, has invented the first combined ... on the same scanning surface. Until now two different scanners ... one scanner can capture both on the same surface. ...
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
(Date:11/24/2015)... ... , ... The Academy of Model Aeronautics (AMA), led by its Executive Council, ... Grand Prix, to represent the First–Person View (FPV) racing community. , FPV racing has ... type of racing and several new model aviation pilots have joined the community because ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... today that the remaining 11,000 post-share consolidation (or ... Warrants (the "Series B Warrants") subject to the ... on November 23, 2015, which will result in ... giving effect to the issuance of such shares, ...
Breaking Biology Technology: